For patients whose skin cancer doesn’t respond to traditional treatments, a new drug called RP1 has been a lifeline—at least for those who can get into a clinical trial. The drug has shown so much promise in...
The Verdict
ClassificationUnsure
ConfidenceMedium confidence
Analyzedtext, image
ImageLikely AI
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/2d9d849f-72a6-4bb3-8440-65b469fce792)